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Abstract
Purpose—To investigate the cellular internalization pathways of shape- and size-specific particles
as a function of zeta potential in different cell types.
Methods—A top-down particle fabrication technique called PRINT was utilized to fabricate
monodisperse 1 μm cylindrical particles. Cellular internalization of these PRINT particles was
monitored using confocal microscopy, flow cytometry, and transmission electron microscopy. The
endocytic pathway used by 1 μm cationic PRINT particles was evaluated using different inhibitory
strategies. Cytotoxicity assays were used to determine the toxicity of both cationic and anionic PRINT
particles in multiple cell types.
Results—Particle internalization was confirmed using confocal microscopy, flow cytometry and
transmission electron microscopy. The mechanism of internalization of positively charged PRINT
particles was found to be predominantly clathrin-mediated endocytosis and macropinocytosis with
very few particles utilizing a caveolae-mediated endocytic pathway. The exposed charge on the
surface of the particles had a significant effect on the rate of endocytosis in all cell types tested, except
for the macrophage cells. No significant cytotoxicity was observed for all PRINT particles used in
the present study.
Conclusions—Cylindrical 1 μm PRINT particles were readily internalized into HeLa, NIH 3T3,
OVCAR-3, MCF-7, and RAW 264.7 cells. Particles with a positive zeta potential exhibited an
enhanced rate of endocytosis compared to negatively charged particles with identical sizes and
shapes. It was found that PRINT particles with a positive zeta potential were endocytosed into HeLa
cells using predominantely clathrin-mediated and macropinocytotic pathways.
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The exploration and utilization of nanocarriers for the delivery of therapeutics in vivo has led
to dramatic improvements in the efficacy of various therapies. Over the past few years, intense
research and development of novel platforms has resulted in drug delivery vehicles such as
polymeric nanoparticles, micelles, immunoconjugates, DNA-polymer conjugates, dendrimers
and liposomes [1–18]. These different vehicles have opened new avenues in the development
of site-specific targeted drug delivery [4–6,8–11,19,20]. Clinically, the success of these carriers
has been limited by the lack of control over size, chemical composition, uniformity, cell
targeting and ability to consistently load and release known amounts of cargo [14,21,22].
Additional challenges faced by liposomal and micellular structures include the fact that they
are dynamic “assemblies” (they are not stable objects) and there is little control over size and
shape, especially over time in the biological milieu [19,23,24]. In addition, there are many
other naturally occurring lipidic membranes present in vivo which lead to fusion and membrane
reorganization and therefore leakage of cargo. Moreover, it is difficult to dial in the amount of
cargo that one can kinetically trap or encapsulate in liposomes and it is even more difficult to
have a series of liposomal structures that can release the cargo at will in a controlled time frame.
Indeed most liposomal systems do not allow one to systematically vary the percentage of the
cargo that can be encapsulated. As a result, in order to study dose dependencies with liposomal
systems, researchers are forced to accomplish such critical experiments by physically blending
liposomes containing cargo with cargoless liposomes in order to vary the dose of drug at
constant liposomal dosing. Controlling the composition, size, shape, functionality and stability
both in vitro and in vivo of nanocarriers is critical to the design of a fully realized delivery
vehicle.
Elucidating the mechanisms by which organic particles of controlled size, shape, site-specific
surface chemistry, tunable particle matrix composition and tunable modulus undergo
endocytosis is of great importance. Understanding the interdependent roles that size, shape and
surface and matrix composition have is particularly important. Once mechanisms of
internalization are established, it is then possible to use these findings to better engineer the
intracellular release of specific cargos. This information, in combination with ongoing efforts
to understand the biodistribution of shape controlled particles [25], will help to establish rules
towards the rational design of nanocarriers for the effective in vivo delivery of various cargos,
especially those cargos that need to be internalized into cells such as siRNA and antisense
oligonucleotides. The major endocytic pathways used by cells, for example, clathrin-mediated,
caveolae-mediated, or macropinocytosis play prominent roles in the uptake and intracellular
trafficking of organic particles. This study utilizes polymer and organic chemistry,
biochemistry, and cell biology to investigate these mechanisms using a novel particle
fabrication method called PRINT™ (Particle Replication In Non-wetting Templates) [22,26].
PRINT takes advantage of the unique properties of elastomeric molds comprised of a low
surface energy perfluoropolyether network, allowing for the production of monodisperse,
shape-specific particles from an extensive array of organic precursors [22,25,26]. Here, we
will explore the internalization mechanisms of non-targeted 1 μm cylindrical PRINT particles.
MATERIALS AND METHODS
Materials
Fluorocur™, the perfluoropolyether used as the molding material in the PRINT process, was
purchased from Liquidia Technologies (Product 2M-140). Trimethylolpropane ethoxylate
triacrylate (Mn=428 g/mol; Aldrich), was passed through a short plug of alumina prior to use
to remove inhibitor. Poly(ethylene glycol) monomethyl ether monomethacrylate (Mn=1,000
g/mol; Polysciences), fluorescein-o-acrylate (Aldrich), 2-aminoethyl methacrylate
hydrochloride (Aldrich) and 2,2-diethoxyaceto-phenone (Aldrich) were used as received
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without further purification. Polyethylene sheeting was purchased from American Plastics
Company. Silicon templates used as masters were obtained from Benchmark Technologies.
Solvents used in the fabrication and purification of PRINT particles (2-propanol, and acetone)
were filtered before use through a 0.22 μm PTFE syringe filter. Borax buffer was obtained
from Ricca Chemical Company. HeLa, NIH 3T3 and RAW 264.7 cell lines were obtained from
ATCC. The Lineberger Cancer Center Tissue Culture Facility, at the University of North
Carolina Chapel Hill supplied the MCF-7 and OVCAR-3 cell lines. All cell culture media
(MEM, OptiMEM) were purchased from the Lineberger Cancer Center Tissue Culture Facility
at the University of North Carolina at Chapel Hill. Invitrogen supplied the GlutaMAX-I. Cell
Titer 96® AQueous One Solution Cell Proliferation Assay was purchased from Promega. The
1.5 G cover slips were obtained from MatTek Corporation, and DRAQ5 was purchased from
Biostatus, Ltd.. Molecular Probes supplied the Alexa Fluor-555 labeled wheat germ agglutinin,
and Polysciences supplied the Polybed 812 epoxy resin. Nocodazole was obtained from Sigma.
Preparation of PRINT Particles
The fabrication of patterned Fluorocur™ molds has been described elsewhere [25,26]. The
particle composition used for the 1 μm particles was 67 wt% trimethylolpropane ethoxylate
triacrylate (MW=428 g/mol), 20 wt % poly(ethylene glycol) monomethylether
monomethacrylate (MW=1,000 g/mol), 10 wt % 2-aminoethyl methacrylate hydrochloride
(AEM HCl), 2 wt % fluorescein-o-acrylate, and 1 wt % 2,2-diethoxyacetophe-none (Fig. 1).
The monomers were weighed out into a 50 ml Falcon tube, then diluted with 2-propanol so
that the solution contained 10 wt% monomers. This solution was sprayed onto a
perfluoropolyether mold using an air gun. The mold was given 10 min to allow for additional
2-propanol evaporation. A polyethylene sheet was placed on top of the mold, and peeled back
at a rate of 10 cm/min. The mold was then placed in a UV curing chamber. The chamber was
purged with nitrogen for 2 minutes, then exposed to UV irradiation (λ = 365 nm, power=20
mW/cm2) for 2 min, thereby curing the particles.
Particles were harvested into a drop of ~5 ml of filtered acetone by sliding a glass slide across
the surface of the mold. By gently applying pressure, the particles were removed from the mold
and were collected into a 50 ml Falcon tube. The particles were spun down using a centrifuge
(IEC CENTRA CL2 Centrifuge, Thermo Electron Corporation) for 10 min at 3200 rpm, and
were then rinsed four times with fresh acetone, dried in a vacuum desiccator overnight,
weighed, then re-dispersed in the appropriate amount of water to make a particle concentration
of 10 mg/ml.
To prepare negatively charged particles, the positively charged particles described above were
redispersed into 5 ml of Borax buffer (instead of water). Next, 1 ml of acetic anhydride was
added to the particle dispersion for 4 h which was found to amidate primary amines on the
surface of the PRINT particles [confirmed by zeta potential measurements (vide infra)]. Once
the reaction was complete, 45 ml of acetone was added to the particle dispersion into a 50 ml
Falcon tube, and the particles were spun down again, rinsed six times in fresh acetone, dried
in a vacuum desiccator overnight, weighed, then redispersed in the appropriate amount of water
to make a particle concentration of 10 mg/ml.
Particle Size Analysis of PRINT Particles using Scanning Electron Microscopy (in the dry
state)
Scanning electron microscopy was used to measure the size of the PRINT particles using a
Hitachi model S-4700 scanning electron microscope. Aqueous dispersions of particles were
placed on a glass slide, the drop was then allowed to dry, and the glass slide was coated with
5.0 nm of Pd/Au alloy using a Cressington 108 auto sputter coater (Cressington Scientific
Instruments Ltd.). Double-sided adhesive tape was used to adhere the Pd/Au coated glass slide
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to the sample holder. The sample was then placed inside the vacuum chamber of the SEM and
observed under low vacuum (10−6 Torr).
Zeta Potential Measurements
The zeta potential of PRINT particles was measured using a ZetaPlus Zeta Potential Analyzer
(Brookhaven Instruments Corporation). The average value was determined from an aqueous
dispersion of PRINT particles at a concentration of 0.3 mg/ml and at a temperature of 25°C.
Cell Lines and Maintenance
HeLa cells were maintained in MEM supplemented with 10% FBS, 2 mM L-glutamine, 1 mM
sodium pyruvate and non-essential amino acids. NIH 3T3 and RAW 264.7 cells were
maintained in DMEM with 10% FBS, 4.5 g/l glucose, 2 mM L-glutamine, and 110 mg/l sodium
pyruvate. MCF-7 cells were grown in RPMI 1640 with 10% FBS, 2 mM L-glutamine, 1 mM
sodium pyruvate, non-essential amino acids, and 10 ug/ml insulin. OVCAR-3 cells were grown
in RPMI 1640 supplemented with 10% FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 10
mM HEPES, 4.5 g/l glucose, and 10 μg/ml human recombinant insulin.
Cell Uptake and Cytotoxicity Assay
HeLa, MCF-7, OVCAR-3 and NIH 3T3 cells were seeded in 96 well plate at 2×104 per well,
and RAW 264.7 cells were seeded at 5×104 per well. Cells were allowed to attach to the plate
overnight at 37°C. The next day, 1 μm particles were vortexed and diluted in OPTI-MEM with
GlutaMAX-I. Cells were briefly washed using OPTI-MEM with GlutaMAX-I and then dosed
with particles for 4 h (50 μl/well). The particles were removed at the end of dosing. For uptake
assays, cells were washed with DPBS and trypsinized. Cells were then treated with 0.1% trypan
blue at room temperature for 10 min to quench the extracellular fluorescence from non-
internalized particles [27]. Finally, cells were washed and resuspended in DPBS and analyzed
on a Cyan flow cytometer (DakoCytomation) with Summit 4.3 software. For the cytotoxicity
assays, 100 μl of complete growth medium was replaced in each well, and 20 μl of Cell Titer
96® AQueous One Solution Cell Proliferation Assay reagent was added and incubated at 37°
C until color was well developed. The adsorptions at 490 nm were taken for analysis.
Confocal Laser Scanning Microscopy
HeLa cells (50,000) were seeded in a T-25 flask for 24 h (37°C, 5% CO2). Following this, cells
were washed one time with D-PBS followed by MEM with supplements containing 1% fetal
bovine serum (low serum). Cells were then incubated for 4 h (37°C, 5% CO2) with low serum
MEM (2 ml) containing 15 μg/ml fluorescein-labeled PRINT particles. The cells were then
detached with trypsin, resuspended in complete MEM containing 10% FBS, replated onto 2
35 mm2 glass bottom dishes with 1.5 G cover slips and allowed to adhere over night at 37°C.
Nuclei were stained with 2.5 μM DRAQ5 in complete MEM following the manufacturer’s
protocol. DRAQ5 is a DNA specific dye with far-red fluorescent properties (Ex: 647 nm, Em:
670 nm) [28]. Plasma membranes were visualized with AlexaFluor-555 labeled wheat germ
agglutinin (WGA) in D-PBS (2.5 μg/ml). Cells were then fixed with 4% paraformaldehyde.
An Olympus FV500 confocal laser scanning microscope (Olympus Co Ltd located in the
Microscopy Laboratory Services, a core facility of the Department of Pathology and
Laboratory Medicine) was used to visualize the cells. Z stacks were collected and used for 3-
D reconstruction and visualization of intracellular uptake and particle localization within the
cells.
Transmission Electron Microscopy (TEM)
Further evidence of particle internalization and translocation was gained using TEM. Here, 60
mm2 polystyrene dishes were used to seed ~5×105 HeLa cells overnight. Cells were treated
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with PRINT particles the following day. Monolayers of cells were rinsed with D-PBS and fixed
in 2% paraformaldehyde/2.5% glutaraldehyde/0.15 M sodium phosphate at pH 7.4, for several
hours or overnight. Following three rinses with sodium phosphate buffer, the monolayers were
post-fixed for 1 h in 1% osmium tetroxide/1.25% potassium ferrocyanide/0.15 M sodium
phosphate buffer. After rinsing in deionized water, the cells were dehydrated using increasing
concentrations of ethanol (30%, 50%, 75%, 100%, 100%, 10 min each) and embedded in
Polybed 812 epoxy resin. A diamond knife was used to section the monolayers both parallel
and perpendicular to the substrate. Ultrathin sections were collected on 200 mesh copper grids
and stained with 4% aqueous uranyl acetate for 15 min, followed by Reynolds’ lead citrate for
7 minutes. A LEO EM910 transmission electron microscope operating at 80 kV (LEO Electron
Microscopy Inc. located at the Microscopy Laboratory Services Core Facility at UNC) was
used to image the samples. Digital images were acquired using a Gatan Orius SC1000 CCD
Digital Camera and Digital Micrograph 3.11.0 (Gatan, Inc.).
Microtubule Disruption
Nocodazole was used to determine the effect of disrupting microtubule depolymerization on
the particle internalization. Cells were pre-incubated with 20 μM Nocodazole in serum-free
MEM for 60 min at 37°C/5% CO2. The media was then removed and replaced with 20 μM
Nocodazole in serum-free MEM containing 15 μg/ml 1 μm PRINT particles. Incubation at 37°
C/5% CO2 was continued for an additional 60 min and then processed by flow analysis.
Energy Dependent Uptake
Cells were pre-incubated in the presence of 0.1% NaN3/50 mM 2-deoxyglucose (NaN3/DOG)
in serum-free MEM for 60 min at 37°C/5% CO2 prior to incubation in the same media
containing 15 μg/ml 1 μm particles. Cells were incubated with particles for 60 min at 37°C/
5% CO2 and then processed for analysis by flow cytometry.
Disruption of Clathrin-mediated Internalization
Cells were incubated in serum-free MEM containing 75 μM Dynasore for 60 min at 37°C/5%
CO2. Cells were subsequently incubated in serum-free MEM/75 μM Dynasore containing 15
μg/ml particles for 60 min and then processed for flow cytometry.
Cholesterol Depletion
Cells were pre-incubated with 2 μg/ml filipin (freshly prepared) in serum-free MEM for 60
min in 37°C/5% CO2. The cells were then incubated in the same media containing 15 μg/ml




The mean size and morphology of the PRINT particles were determined by SEM. The results
show that the particles have a mean width of 1.00±0.06 μm, a mean height of 0.68±0.05 μm,
with an apparent meniscus on one side of the particle (Fig. 2). The zeta potential of the
positively charged particles was measured to be +23±3 mV using a ZetaPlus Zeta Potential
Analyzer. Upon reaction of the surface amine groups with acetic anhydride for 4 h, the zeta
potential changed from +23±3 mV to −19±3 mV.
Particle Internalization
Internalized particles were observed using multiple techniques including confocal microscopy,
flow cytometry, and transmission electron microscopy (TEM). Figure 3 shows confocal
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micrographs of HeLa cells with internalized PRINT particles possessing a positive surface
charge. In these experiments, cells were stained with AlexaFluor-555 labeled WGA to visualize
the plasma membrane, and DRAQ5 to differentiate the cellular nucleus. Z stacks were collected
and used for 3-D reconstruction and visualization of intracellular particle localization.
Additionally, transmission electron micrographs were obtained to further demonstrate cellular
internalization. Figure 4 shows 1 μm PRINT internalized particles in HeLa cells using TEM.
It should be noted that multiple 1 μm PRINT particles can be internalized into a single cell.
Particle Internalization Pathways
Chemical inhibitors were used to assess the pathways used by HeLa cells to internalize 1 μm
positively charged PRINT particles (Fig. 5). First, NaN3/2-deoxyglucose (NaN3/DOG) was
exposed to the cells and a 70% decrease in internalization was observed signifying that the
internalization pathways were energy dependent. The combination of NaN3 and DOG impairs
energy dependent translocation events by depleting ATP [29]. Filipin, a polyene antibiotic
which sequesters plasma membrane cholesterol was used to investigate particle internalization
by a caveloae-mediated mechanism. A ~2% decrease in internalization was seen when filipin
was used to inhibit endocytosis. Dynasore, a cell permeable reversible inhibitor of dynamin
was used to probe internalization via clathrin-coated pits [30]. Here, a 35% decrease in
internalization of PRINT particles was seen. Finally, Nocodazole was used as an inhibitor of
macro-pinocyotsis. Using Nocodazole, a 16% decrease in internalization was observed. These
results suggest that multiple pathways are utilized for the internalization of PRINT particles
into HeLa cells, with the predominant pathways being clathrin-mediated endocytosis, and
macropinocytosis.
The Effect of Charge on Internalization
Flow cytometry was used as an additional in vitro technique to confirm cellular internalization.
Here, positively and negatively charged PRINT particles were dosed onto HeLa (human
epithelial carcinoma cells), NIH 3T3 (mouse embryonic fibroblast cells), OVCAR-3 (human
ovarian carcinoma cells), MCF-7 (human breast adenocarcinoma cells), and RAW 264.7
(mouse leukaemic monocyte macrophage cells) for either 1 or 4 h of incubation (Fig. 6).
Following several rinsing steps attempting to remove any membrane-bound or non-internalized
particles, the percent of cells with internalized particles was measured on a Dako flow
cytometer. With the exception of the macrophage cell line where there was no preferential
internalization based on charge, all cells clearly show a preferential uptake of the positively
charged particles over the negatively charged particles at all particle dosings tested (up to 360
μg/ml).
Specifically, it was found that at a particle concentration of 100 μg/ml, positively charged were
internalized into ~100% of all the HeLa cells being analyzed, whereas only ~60% of the
negatively charged particles were internalized at similar concentrations. When NIH 3T3 cells
were investigated at the same particle concentration, a larger discrepancy was seen between
the positively and negatively charged PRINT particles. Here, the positively charged particles
were internalized by ~100% of the cells, while the negatively charged particles were only
internalized by ~40% of the cells. In contrast, OVCAR-3 cells seemed to be less discriminatory,
with ~100% of cells possessing an internalized positively charged particle, and ~80% of cells
having an internalized negatively charged particle, both at particle concentrations of 100 μg/
ml. An additional cancer cell line was examined, MCF-7 cells, which showed a more
pronounced preference for the positively charged particles. In this case, at 100 μg/ml, ~80%
of cells contained an internalized positively charged particle, whereas only ~40% of cells
contained an internalized negatively charged particle. Finally, the macrophage cell line showed
little, if any, effect of charge on particle internalization at all particle concentrations. For
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example, at 100 μg/ml ~85% of cells contained an internalized positively charged particle, and
~75% of cells contained an internalized negatively charged particle.
Cytotoxicity
The cytotoxicity of the PRINT particles used herein was evaluated using HeLa, NIH 3T3,
OVCAR-3, MCF-7, and RAW 264.7 cells after 4 h of incubation with both positively and
negatively charged 1 μm PRINT particles. In all five cell lines tested, no significant amount
of cytotoxicity was observed (Fig. 6). Moreover, no observable cell death was seen for particles
having either positive or negative zeta potentials. However, several cells lines showed a slight
decrease in cell viability with an increase in particle concentration, while remaining relatively
non-toxic. For example, HeLa cells show a ~12% decrease in cell viability once both positively
and negatively charged particle concentrations were increased to 200 μg/ml and RAW 264.7
cells showed a decrease in cell viability (~13%) for both charged particles at concentrations
of 125 μg/ml. For the remaining cell lines, i.e. NIH 3T3, OVCAR-3 and MCF-7, both surface
charges showed no observable cell death at particle concentrations as high as 200 μg/ml. For
all cell lines, cytotoxicity tests were performed with extended times (out to 72 h), with no
significant amount of cell death observed (data not shown). It should be noted that all in
vitro work performed in this study for confocal microscopy, inhibitory studies, and TEM were
done at particle concentrations of 15 μg/ml, where no cytotoxicity was observed for any of the
cell lines examined.
DISCUSSION
Major strides towards improving current particle delivery technologies will be possible once
an understanding of the fate of particles in vitro and in vivo is clearly understood. Heretofore,
this knowledge was difficult to ascertain due to the lack of “calibration quality” particles, where
size, shape and surface chemistry is controlled and identical across all particles in a given lot
of particles. PRINT technology allows for the fabrication of “calibration quality” particles with
complete control over size, shape, and surface chemistry. In these studies, 1 μm cylindrical
particles were chosen to facilitate microscopy studies where the visualization of individual
internalized particles was possible. The size and shape of the cylindrical particles was examined
using SEM (Fig. 2). The cylindrical particles display a meniscus on one side of the particles,
which is a direct result of the PRINT process where capillary action is used to fill the
perfluoropolyether molds. Once the liquid in the PRINT molds is polymerized, the meniscus
becomes a permanent part of the particle shape.
Particle internalization was monitored using confocal microscopy, transmission electron
microscopy (TEM), and flow cytometry. Figure 3 shows internalized 1 μm positively charged
PRINT particles into HeLa cells by confocal microscopy. In these experiments both the plasma
membrane and the nuclear membrane were stained to aid in differentiating membrane-bound
particles from those that were internalized. Z stacks were collected and used for 3-D
reconstruction of the internalized particles to further show internalized particles and
intracellular location. TEM micrographs clearly show internalized 1 μm positively charged
PRINT particles into HeLa cells, and the translocation of these particles (Fig. 4). Both confocal
microscopy and TEM show the translocation of the positively charged PRINT particles to the
perinuclear region of the cell, where, within a 60 minute incubation period, the majority of the
internalized particles are localized at the perinuclear region of the cells. It should be noted that
it is possible for more than one particle to be internalized into a single cell, as seen by both
confocal microscopy and TEM.
In order to further understand the fate of particles once internalized, a series of inhibitors were
used to examine the endocytic pathways used by positively charge PRINT particles (Fig. 5).
Based on the results obtained, all particle internalization occurs via an energy dependent
Gratton et al. Page 7













process as seen by the drastic decrease in internalization once NaN3/DOG is applied to the
cells (~70% decrease). NaN3/DOG is known to block ATP synthesis and to impair energy
dependent translocation. It is thought that complete inhibition was not accomplished due to
exogenous ATP and glucose which are present in the serum-free media. Dynasore was used
to inhibit clathrin-coated pit pathways by acting as a Dynamin GTPase inhibitor, and a ~35%
decrease was observed in particle internalization with this inhibitory process. A ~16% decrease
in internalization was observed when the macropinocytosis pathways were inhibited by
inhibiting the microtubule depolymerization using Nocodazole. In contrast, only a ~2%
decrease in internalization was seen when a caveolae inhibitor, filipin was used. Filipin is a
polyene antibiotic which is known to bind cholesterol in the plasma membrane and inhibit
caveolae-mediated endocytosis. It should be noted that additional modes of endocytosis exist
such as non-clathrin, non-caveolae mediated endocytosis, which were not screened in the
inhibition studies and could account for supplementary pathways of internalization utilized by
these cationic 1 μm PRINT particles. Based on these results, it can be said that 1 μm positively
charged cylindrical PRINT particles are internalized using multiple pathways into the cell, and
that internalization occurs predominantly by a clathrin-mediated endocytic pathway as well as
macropinocytosis and not via caveolae-mediated endocytosis to any significant amount.
The effect that charge has on cellular internalization pathways has been studied [31]. It has
been shown that positively charged D,L-poly(lactide) particles are internalized into HeLa cells
using clathrin-mediated pathways whereas negatively charged D,L-poly(lactide) particles do
not utilize the clathrin-mediated endocytotic pathway. Despite this study, little is known about
the mechanism of the endocytotic machinery involved with internalized non-spherical
particles, especially as a function of size, as well as the intracellular trafficking that takes place
with non-spherical particles. To determine the effect of charge on different types of cells,
negatively charged particles were also synthesized. Treating the surface amine groups of the
positively charged particles with acetic anhydride in Borax buffer changed the zeta potential
from +23±3 mV to −19±3 mV. Here, the negatively charged particles have retained the exact
shape of the positively charged particles used in these studies, which showcases the ease of
transformations of the surface chemistry on PRINT particles. In order to determine the effect
of charge in multiple different cell lines, HeLa (human epithelial carcinoma), NIH 3T3 (mouse
embryonic fibroblast), OVCAR-3 (human ovarian carcinoma), MCF-7 (human breast
adenocarcinoma), and RAW 264.7 (mouse leukaemic monocyte macrophage) cells were used.
In these experiments, HeLa, NIH 3T3, OVCAR-3, and MCF-7 cells all displayed a decreased
rate of endocytosis with the negatively charged particles when compared to the identically
sized and shaped positively charged particles at all particle concentrations tested (Fig. 6). In
contrast, the RAW 264.7 macrophage cells showed no preferential uptake of positively charged
particles over the negatively charged particles. In this series of experiments, both 1 and 4 h
particle incubation times were examined, with little difference in cellular internalization
observed with increased incubation times. These results suggest that a targeted particle therapy
could be achieved at the appropriate particle dosing levels (~15 μg/ml) using negatively
charged particles with a targeting ligand thereby avoiding non-specific uptake and increasing
targeting efficiencies into the desired cells.
Since it is known that positively charged particles can induce cytotoxic effects, all particles
used in this study were examined for cytotoxicity. It is thought that positively charged particles
can disrupt the cellular membrane through electrostatic interactions with the cell membrane
phospholipids [32,33]. In all cell lines tested, no significant cytotoxicity was observed after a
4 h incubation period with the cells (Fig. 6). The cytotoxicity assays were taken out to 72 h
with no significant observable cell death.
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A complete understanding of the molecular mechanisms involved for the internalization of
particles into cells, as well as their fate once internalized, is crucial to the development of
successful particle therapies. Here, we describe some initial studies investigating the endocytic
pathways involved in particle internalization, as well as the effects of internalization based on
particles having identical sizes, and shapes, but different surface chemistry, where one has a
positive zeta potential and the other had a negative zeta potential. A pronounced preference
for positively charged particles was seen in all cell lines except for the macrophage cells.
Cytotoxicity was performed on all cell lines using both positively and negatively charged
particles with no significant toxicity observed at all particle concentrations tested. Obtaining
knowledge on the endocytic pathway used from “calibration quality” particles should lead to
crucial information required for not only enhancing specific cellular internalization, but also
manipulating the intracellular location of particles, and minimizing cytotoxic effects.
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Chemical structures of monomers and a partial structure of the PRINT particles.
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A representative scanning electron micrograph of the 1 μm cylindrical particles used in the
present study.
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Confocal micrographs of 1 μm PRINT particles internalized in HeLa cells after a 4 h incubation
period.
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Transmission electron micrographs of 1 μm PRINT particles internalized in HeLa cells after
a 4 h incubation period.
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Determining the cellular internalization pathway of 1 μm positively charged PRINT particles.
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Internalization of 1 μm PRINT particles by various cell lines. Cells were dosed with various
concentrations of particles for 4 h at 37°C. A Cellular internalization profiles; B cytotoxicity
of particles. Red circles represent positively charged particles; blue circles represent negatively
charged particles. The data shown were representative of more than three separate experiments.
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